Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.

Vemula S, Roder KE, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ.

J Pharmacol Exp Ther. 2009 Feb;328(2):487-95. doi: 10.1124/jpet.108.146589. Epub 2008 Nov 3.

2.
3.

Protein kinase C family members as a target for regulation of blood-brain barrier Na,K,2Cl-cotransporter during in vitro stroke conditions and nicotine exposure.

Yang T, Roder KE, Bhat GJ, Thekkumkara TJ, Abbruscato TJ.

Pharm Res. 2006 Feb;23(2):291-302. Epub 2006 Feb 7.

PMID:
16450214
4.

Tobacco smoke chemicals attenuate brain-to-blood potassium transport mediated by the Na,K,2Cl-cotransporter during hypoxia-reoxygenation.

Paulson JR, Roder KE, McAfee G, Allen DD, Van der Schyf CJ, Abbruscato TJ.

J Pharmacol Exp Ther. 2006 Jan;316(1):248-54. Epub 2005 Sep 20.

PMID:
16174793
5.

Brain uptake of thiamine-coated nanoparticles.

Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD.

J Control Release. 2003 Dec 12;93(3):271-82.

PMID:
14644577
6.

In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Lockman PR, Koziara J, Roder KE, Paulson J, Abbruscato TJ, Mumper RJ, Allen DD.

Pharm Res. 2003 May;20(5):705-13.

PMID:
12751624
7.

Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.

Allen DD, Lockman PR, Roder KE, Dwoskin LP, Crooks PA.

J Pharmacol Exp Ther. 2003 Mar;304(3):1268-74.

PMID:
12604705
8.

Inhibition of the rat blood-brain barrier choline transporter by manganese chloride.

Lockman PR, Roder KE, Allen DD.

J Neurochem. 2001 Nov;79(3):588-94.

Supplemental Content

Loading ...
Support Center